CompletedPhase 3NCT02927496
A 24 Month Study, to Compare the Efficacy of Doxycycline vs. Placebo for Improving Filarial Lymphedema in Mali
Studying Filariasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- The Task Force for Global Health
- Principal Investigator
- Eric Ottesen, MDNeglected Tropical Disease Support Center
- Intervention
- Doxycycline(drug)
- Enrollment
- 220 enrolled
- Eligibility
- 14-65 years · All sexes
- Timeline
- 2018 – 2020
Study locations (1)
- International Centers for Excellence in Research-Mali, Filariasis Res. Unit., Bamako, Mali
Collaborators
United States Agency for International Development (USAID)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02927496 on ClinicalTrials.govOther trials for Filariasis
Additional recruiting or active studies for the same condition.